Impact of formulary restrictions on medication intensification in diabetes treatment.

CONCLUSIONS: Part D formulary restrictions on sole-source brand name NIADs had little impact on patterns of treatment intensification for T2D among LIS recipients enrolled in Medicare Part D plans in 2012.
PMID: 29851442 [PubMed - in process]

Source: The American Journal of Managed Care - May 1, 2018 Category: Health Management Authors: Stuart BC, Slejko JF, Rueda JD, Cooke C, Shen X, Roberto P, Ciarametaro M, Dubois R Tags: Am J Manag Care Source Type: research